Thomas E. Hancock's most recent trade in Kiora Pharmaceuticals Inc was a trade of 3,333 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 1, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Kiora Pharmaceuticals Inc | Thomas E. Hancock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 3,333 | 3,333 | - | - | Stock Option (right to buy) |